Elevating DANCR in normal breast epithelial cells or breast cancer cells of low malignancy increased the production of inflammatory cytokines, stimulated the binding of EZH2 to SOCS3 promoter, and down‐regulated SOCS3. Here, EZH2 is linked to breast cancer.